People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies, insulin administration is manually controlled, while hybrid ...
A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced hypoglycemia from 4.01% to 0.52% in diabetic rats. (Nanowerk Spotlight) An ...
Closed-loop control systems of insulin delivery may improve glycemic outcomes in young children with type 1 diabetes. The efficacy and safety of initiating a closed-loop system virtually are unclear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results